Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro
Xie, H., Su, H.X., Li, M.J., Xu, Y.C.(2025) Nat Commun 
Experimental Data Snapshot
Starting Model: experimental
View more details
wwPDB Validation   3D Report Full Report
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Receptor-interacting serine/threonine-protein kinase 3 | 325 | Mus musculus | Mutation(s): 0  Gene Names: Ripk3, Rip3 EC: 2.7.11.1 | ![]() | |
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for Q9QZL0 (Mus musculus) Explore Q9QZL0  Go to UniProtKB:  Q9QZL0 | |||||
IMPC:  MGI:2154952 | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | Q9QZL0 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
A1D97 (Subject of Investigation/LOI) Query on A1D97 | C [auth A], D [auth B] | 2-cyclopentyl-~{N}-(6-propan-2-ylsulfonylquinolin-4-yl)-1,3-benzothiazol-5-amine C24 H25 N3 O2 S2 PVKIFNZMYGMWPD-UHFFFAOYSA-N |
Length ( ? ) | Angle ( ? ) |
---|---|
a = 47.7 | ¦Á = 99.26 |
b = 56.157 | ¦Â = 114.15 |
c = 57.975 | ¦Ă = 89.91 |
Software Name | Purpose |
---|---|
PHENIX | refinement |
Aimless | data scaling |
PHASER | phasing |
xia2 | data reduction |
Funding Organization | Location | Grant Number |
---|---|---|
Not funded | -- |